The Impact on Cognitive Health
Natural frequencies, such as the Schumann and embryonic frequencies, are receiving increasing attention in neuroscience. These frequencies have been associated with beneficial effects on the brain, including enhancing neuronal connectivity, regulating brain activity, and providing neuroprotection against inflammation. Scientific interest in these phenomena is driven by studies that explore how exposure to these frequencies can potentially support cognitive function and improve quality of life for people with neurodegenerative disorders or learning disabilities. This article brings together excerpts from studies detailing the impact of frequencies on aspects such as memory, attention, and neuroplasticity.
Improved Neural Connectivity: The Schumann frequency is associated with brainwave alignment, particularly alpha waves, which are linked to relaxation and alertness. Increased alpha wave synchronization may help stabilize cognitive function in people with neurodegenerative diseases such as Alzheimer’s or Parkinson’s. Studies have shown that improving neural connectivity and reducing brainwave imbalances may slow the progression of some cognitive symptoms associated with these diseases.
Neuroprotection and Inflammation Reduction: Some research suggests that exposure to Schumann and embryonic frequencies may have a neuroprotective effect by reducing brain inflammation, which is often present in neurodegenerative diseases. By modulating the inflammatory response and promoting a more stable neuronal environment, these frequencies may help delay cellular degeneration and improve patients' quality of life.
Brain Activity Regulation: Attention disorders, such as ADHD, are often associated with an imbalance in brain waves, with some frequencies (such as beta waves) being overactive and others (such as alpha and theta waves) being underactive. Using the Schumann frequency can help rebalance these brain waves, promoting better focus and attention control. Some neurofeedback therapies use frequencies close to 7.83 Hz to regulate brain activity in people with ADHD.
Improved Memory and Learning Abilities: Schumann and embryonic frequencies may also improve memory and learning by facilitating the transition between alpha and theta states of consciousness, which are associated with learning and memory consolidation. By helping the brain reach these states more consistently, these frequencies may support the processes of memorization and acquisition of new skills.
Neuroscience Studies: Studies on the use of specific frequencies to treat cognitive disorders have shown that exposure to low frequencies can improve brain wave regulation and potentially reduce symptoms of neurocognitive disorders. For example, research published in Neuroscience Letters showed that low-frequency transcranial magnetic stimulation could improve cognition in patients with neurodegenerative diseases.
Electromagnetic Stimulation Therapies: Other research in electrotherapy and brain stimulation has explored the use of frequencies such as 2.28 Hz to positively influence cognitive functions. These studies suggest that such frequencies can modulate neural activity, improve connectivity between brain regions involved in attention and learning, and provide support to patients with cognitive disorders.
Support for Learning and Memory: In relation to learning disorders such as dyslexia, some studies are exploring the use of Schumann and embryonic frequencies to improve reading and comprehension ability by modulating brain activity in areas involved in language and sensory integration. Improving neural plasticity through exposure to these frequencies could also facilitate the creation of new neural connections, essential for overcoming learning obstacles.
Current and Future Studies Research Projects: Several research projects and clinical studies are underway to evaluate the effectiveness of Schumann and embryonic frequencies in the care of patients with neurocognitive disorders. These studies include trials on brain wave modulation, effects on biomarkers of stress and inflammation, and long-term impacts on patients' quality of life.